Literature DB >> 17189427

Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function.

Palle G Laustsen1, Steven J Russell, Lei Cui, Amelia Entingh-Pearsall, Martin Holzenberger, Ronglih Liao, C Ronald Kahn.   

Abstract

Cardiovascular disease is the leading cause of death in people with type 2 diabetes and is linked to insulin resistance even in the absence of diabetes. Here we show that mice with combined deficiency of the insulin receptor and insulin-like growth factor 1 (IGF-1) receptor in cardiac and skeletal muscle develop early-onset dilated cardiomyopathy and die from heart failure within the first month of life despite having a normal glucose homeostasis. Mice lacking the insulin receptor show impaired cardiac performance at 6 months, and mice lacking the insulin receptor plus one Igf1r allele have slightly increased mortality. By contrast, mice lacking the IGF-1 receptor or the IGF-1 receptor plus one Ir allele appear normal. Morphological characterization and oligonucleotide array analysis of gene expression demonstrate that prior to development of these physiological defects, mice with combined deficiency of both insulin and IGF-1 receptors have a coordinated down-regulation of genes encoding components of the electron transport chain and mitochondrial fatty acid beta-oxidation pathways and altered expression of contractile proteins. Thus, while neither the insulin receptor nor IGF-1 receptor in muscle is critical for glucose homeostasis during the first month of life, signaling from these receptors, particularly the insulin receptor, is required for normal cardiac metabolism and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189427      PMCID: PMC1820447          DOI: 10.1128/MCB.01110-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

Authors:  A Zisman; O D Peroni; E D Abel; M D Michael; F Mauvais-Jarvis; B B Lowell; J F Wojtaszewski; M F Hirshman; A Virkamaki; L J Goodyear; C R Kahn; B B Kahn
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 3.  At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function.

Authors:  W Glen Pyle; R John Solaro
Journal:  Circ Res       Date:  2004-02-20       Impact factor: 17.367

4.  A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit.

Authors:  M Holzenberger; P Leneuve; G Hamard; B Ducos; L Perin; M Binoux; Y Le Bouc
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

5.  Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter.

Authors:  Y Aihara; M Kurabayashi; Y Saito; Y Ohyama; T Tanaka; S Takeda; K Tomaru; K Sekiguchi; M Arai; T Nakamura; R Nagai
Journal:  Hypertension       Date:  2000-07       Impact factor: 10.190

6.  Mitochondrial dysfunction and type 2 diabetes.

Authors:  Bradford B Lowell; Gerald I Shulman
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

7.  Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects.

Authors:  J C Tardiff; T E Hewett; S M Factor; K L Vikstrom; J Robbins; L A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-02       Impact factor: 4.733

8.  Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle.

Authors:  J K Kim; M D Michael; S F Previs; O D Peroni; F Mauvais-Jarvis; S Neschen; B B Kahn; C R Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 9.  Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention.

Authors:  M Laakso
Journal:  J Intern Med       Date:  2001-03       Impact factor: 8.989

10.  Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.

Authors:  M L Bang; R E Mudry; A S McElhinny; K Trombitás; A J Geach; R Yamasaki; H Sorimachi; H Granzier; C C Gregorio; S Labeit
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  73 in total

Review 1.  Telomeres and mitochondria in the aging heart.

Authors:  Javid Moslehi; Ronald A DePinho; Ergün Sahin
Journal:  Circ Res       Date:  2012-04-27       Impact factor: 17.367

2.  Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.

Authors:  Golareh Agha; Michael M Mendelson; Cavin K Ward-Caviness; Roby Joehanes; TianXiao Huan; Rahul Gondalia; Elias Salfati; Jennifer A Brody; Giovanni Fiorito; Jan Bressler; Brian H Chen; Symen Ligthart; Simonetta Guarrera; Elena Colicino; Allan C Just; Simone Wahl; Christian Gieger; Amy R Vandiver; Toshiko Tanaka; Dena G Hernandez; Luke C Pilling; Andrew B Singleton; Carlotta Sacerdote; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Yun Li; Guosheng Zhang; James D Stewart; James S Floyd; Kerri L Wiggins; Jerome I Rotter; Michael Multhaup; Kelly Bakulski; Steven Horvath; Philip S Tsao; Devin M Absher; Pantel Vokonas; Joel Hirschhorn; M Daniele Fallin; Chunyu Liu; Stefania Bandinelli; Eric Boerwinkle; Abbas Dehghan; Joel D Schwartz; Bruce M Psaty; Andrew P Feinberg; Lifang Hou; Luigi Ferrucci; Nona Sotoodehnia; Giuseppe Matullo; Annette Peters; Myriam Fornage; Themistocles L Assimes; Eric A Whitsel; Daniel Levy; Andrea A Baccarelli
Journal:  Circulation       Date:  2019-08-19       Impact factor: 29.690

3.  Insulin receptor substrate signaling suppresses neonatal autophagy in the heart.

Authors:  Christian Riehle; Adam R Wende; Sandra Sena; Karla Maria Pires; Renata Oliveira Pereira; Yi Zhu; Heiko Bugger; Deborah Frank; Jack Bevins; Dong Chen; Cynthia N Perry; Xiaocheng C Dong; Steven Valdez; Monika Rech; Xiaoming Sheng; Bart C Weimer; Roberta A Gottlieb; Morris F White; E Dale Abel
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

4.  Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function.

Authors:  Katsuhiko Funai; Irfan J Lodhi; Larry D Spears; Li Yin; Haowei Song; Samuel Klein; Clay F Semenkovich
Journal:  Diabetes       Date:  2015-10-28       Impact factor: 9.461

Review 5.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

6.  Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy.

Authors:  Ali M Tabish; Mohammed Arif; Taejeong Song; Zaher Elbeck; Richard C Becker; Ralph Knöll; Sakthivel Sadayappan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-26       Impact factor: 4.733

7.  Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy.

Authors:  Chen-Ching Lin; Jen-Tsung Hsiang; Chia-Yi Wu; Yen-Jen Oyang; Hsueh-Fen Juan; Hsuan-Cheng Huang
Journal:  BMC Syst Biol       Date:  2010-10-15

Review 8.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Rapid and pervasive changes in genome-wide enhancer usage during mammalian development.

Authors:  Alex S Nord; Matthew J Blow; Catia Attanasio; Jennifer A Akiyama; Amy Holt; Roya Hosseini; Sengthavy Phouanenavong; Ingrid Plajzer-Frick; Malak Shoukry; Veena Afzal; John L R Rubenstein; Edward M Rubin; Len A Pennacchio; Axel Visel
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

Review 10.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.